Bruker | BRKR - Equity Capital And Reserves


Bruker reported $2.46B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
ABB USD 16.4B 1.04B Jun/2026
Agilent USD 7.12B 214M Mar/2026
Ametek USD 10.92B 290.51M Mar/2026
Bio Techne USD 2.09B 74.32M Mar/2026
Bio-Rad Laboratories USD 6.85B 602.3M Mar/2026
Bruker USD 2.46B 35.9M Dec/2025
Charles River Laboratories USD 2.9B 265.94M Mar/2026
Danaher USD 52.95B 415M Mar/2026
Fujikura JPY 560.37B 53.36B Mar/2026
Furukawa JPY 135.3B 1.15B Dec/2025
General Electric Aerospace USD 17.64B 417M Jun/2026
Hitachi JPY 6.57T 211.91B Mar/2026
Illumina USD 2.68B 47M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Mettler Toledo International USD -41.88M 18.25M Mar/2026
Mitsubishi Electric JPY 4.16T 114.12B Dec/2025
Mitsubishi Heavy Industries JPY 3.09T 435.54B Mar/2026
Myriad Genetics USD 337.4M 30.6M Mar/2026
Nikon Corporation JPY 586.79B 10.56B Mar/2026
Olympus JPY 812.04B 38.69B Mar/2026
Repligen USD 2.11B 666K Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
Smiths GBP 1.66B 616M Jun/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Waters USD 2.56B 230.55M Dec/2025